These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 19811249)

  • 1. Type and route of estrogen administration.
    Stevenson JC
    Climacteric; 2009; 12 Suppl 1():86-90. PubMed ID: 19811249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of hormone replacement therapy and route of administration on selected cardiovascular risk factors in post-menopausal women.
    Seed M; Sands RH; McLaren M; Kirk G; Darko D
    Fam Pract; 2000 Dec; 17(6):497-507. PubMed ID: 11120722
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral versus transdermal hormone replacement therapy.
    Stevenson JC; Crook D; Godsland IF; Lees B; Whitehead MI
    Int J Fertil Menopausal Stud; 1993; 38 Suppl 1():30-5. PubMed ID: 8499957
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Are all estrogens created equal? A review of oral vs. transdermal therapy.
    Goodman MP
    J Womens Health (Larchmt); 2012 Feb; 21(2):161-9. PubMed ID: 22011208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The menopause and hormone replacement therapy: lipids, lipoproteins, coagulation and fibrinolytic factors.
    Tikkanen MJ
    Maturitas; 1996 Mar; 23(2):209-16. PubMed ID: 8735358
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of postmenopausal hormone replacement therapy on lipid, lipoprotein, and apolipoprotein (a) concentrations: analysis of studies published from 1974-2000.
    Godsland IF
    Fertil Steril; 2001 May; 75(5):898-915. PubMed ID: 11334901
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Could transdermal estradiol + progesterone be a safer postmenopausal HRT? A review.
    L'hermite M; Simoncini T; Fuller S; Genazzani AR
    Maturitas; 2008; 60(3-4):185-201. PubMed ID: 18775609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of modified transdermal hormone replacement therapy on the concentrations of hormones, growth factors, and bone mineral density in women with osteopenia.
    Stanosz S; Zochowska E; Safranow K; Sieja K; Stanosz M
    Metabolism; 2009 Jan; 58(1):1-7. PubMed ID: 19059524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of estrone on thrombin generation may explain the different thrombotic risk between oral and transdermal hormone replacement therapy.
    Bagot CN; Marsh MS; Whitehead M; Sherwood R; Roberts L; Patel RK; Arya R
    J Thromb Haemost; 2010 Aug; 8(8):1736-44. PubMed ID: 20553380
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral versus non-oral hormone replacement therapy: how important is the route of administration?
    John SC; Malcolm W
    Ginekol Pol; 2007 Jul; 78(7):514-20. PubMed ID: 17915406
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of hormone replacement therapy and tibolone on lipoprotein (a) concentrations in postmenopausal women: A systematic review and meta-analysis.
    Anagnostis P; Galanis P; Chatzistergiou V; Stevenson JC; Godsland IF; Lambrinoudaki I; Theodorou M; Goulis DG
    Maturitas; 2017 May; 99():27-36. PubMed ID: 28364865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Handling hormone replacement therapy: key issues for the prescriber.
    Stevenson JC
    Eur J Obstet Gynecol Reprod Biol; 1996 Apr; 64 Suppl():S25-7. PubMed ID: 8732470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of transdermal versus oral hormone replacement therapy in postmenopause: a systematic review.
    Goldštajn MŠ; Mikuš M; Ferrari FA; Bosco M; Uccella S; Noventa M; Török P; Terzic S; Laganà AS; Garzon S
    Arch Gynecol Obstet; 2023 Jun; 307(6):1727-1745. PubMed ID: 35713694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HRT optimization, using transdermal estradiol plus micronized progesterone, a safer HRT.
    L'Hermite M
    Climacteric; 2013 Aug; 16 Suppl 1():44-53. PubMed ID: 23848491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Menopause and cardiovascular risk].
    Dessapt AL; Gourdy P
    J Gynecol Obstet Biol Reprod (Paris); 2012 Nov; 41(7 Suppl):F13-9. PubMed ID: 23041081
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of circulating cellular adhesion molecules with menopausal status and hormone replacement therapy. Time-dependent change in transdermal, but not oral estrogen users.
    Oger E; Alhenc-Gelas M; Plu-Bureau G; Mennen L; Cambillau M; Guize L; Pujol Y; Scarabin P
    Thromb Res; 2001 Jan; 101(2):35-43. PubMed ID: 11342204
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transdermal estradiol and lipid profile: effects on a specific group of Brazilian postmenopausal women.
    Callejon DR; Rios DR; Franceschini SA; Toloi MR
    Arq Bras Cardiol; 2009 Dec; 93(6):571-5, 617-22. PubMed ID: 20379635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Should transdermal rather than oral estrogens be used in menopausal hormone therapy? A review.
    Fournier A
    Menopause Int; 2010 Mar; 16(1):23-32. PubMed ID: 20424283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential effects of oral conjugated equine estrogen and transdermal estrogen on atherosclerotic vascular disease risk markers and endothelial function in healthy postmenopausal women.
    Ho JY; Chen MJ; Sheu WH; Yi YC; Tsai AC; Guu HF; Ho ES
    Hum Reprod; 2006 Oct; 21(10):2715-20. PubMed ID: 16807281
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sex hormone replacement therapy and modulation of vascular function in cardiovascular disease.
    Koledova VV; Khalil RA
    Expert Rev Cardiovasc Ther; 2007 Jul; 5(4):777-89. PubMed ID: 17605655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.